US Stock MarketDetailed Quotes

ZNTL Zentalis Pharmaceuticals

Watchlist
  • 10.985
  • -0.785-6.67%
Close Apr 25 16:00 ET
  • 10.985
  • 0.0000.00%
Post 16:20 ET
779.50MMarket Cap-2457P/E (TTM)

About Zentalis Pharmaceuticals Company

Zentalis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering and developing clinically differentiated, novel small molecule therapeutics targeting fundamental biological pathways of cancer. It develops a broad pipeline of product candidates with an initial focus on validated oncology targets with the potential to address large patient populations. The company was founded by Kevin D. Bunker and Cam Gallagher on December 23, 2014 and is headquartered in New York, NY.

Company Profile

SymbolZNTL
Company NameZentalis Pharmaceuticals
Listing DateApr 3, 2020
Issue Price18.00
Founded2014
CEODr. Kimberly L. Blackwell, M.D.
MarketNASDAQ
Employees168
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address1359 Broadway,Suite 801
CityNew York
ProvinceNew York
CountryUnited States of America
Zip Code10018
Phone1-212-433-3791
Websitehttp://www.zentalis.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Kimberly L. Blackwell, M.D.
  • Director and Chief Executive Officer
  • 36.61M
  • Cam S. Gallagher
  • Director, President, Interim Chief Financial Officer and Treasurer
  • 10.63M
  • Dr. Diana F. Hausman, M.D.
  • Chief Medical Officer
  • --
  • Dr. Kyle Rasbach, PhD,Pharm.D.
  • Chief Business Officer
  • --
  • Vincent Vultaggio
  • Vice President, Finance and Interim Principal Accounting Officer
  • --
  • David M. Johnson
  • Chairman of the Board
  • 786.05K
  • Dr. Jan Skvarka
  • Independent Director
  • 1.11M
  • Karan S. Takhar
  • Independent Director
  • --
  • Dr. Enoch Kariuki, Pharm.D.
  • Independent Director
  • 666.43K
  • Andrea Paul
  • General Counsel and Corporate Secretary
  • 6.21M

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg